Delivery Order SPE2DB20D3103-SPE2DB22FN3C2

Award Date 4/8/22
Potential Completion Date 4/11/22
Potential Value $11K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,151.10 firm fixed-price delivery order is for the supply of Lidocaine-Prilocaine Cream, a topical anesthetic medication. The contract has a period of performance through March 14, 2023 and was awarded on March 13, 2023. This award is under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,960.38 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of 4557551380 - Lidocaine-Prilocaine Cream 30GM. This delivery order was issued under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The award did not have a set-aside designation, indicating full and open...
This is a $1,010.76 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lidocaine-Prilocaine Cream, a topical anesthetic used for medical purposes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Lidocaine-Prilocaine creams. The $1,995.76 firm fixed-price contract has an ultimate completion date of December 29, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, valued at up to $999,999,999.00 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,411.43 firm fixed-price delivery order is for the supply of 4562172674 Lidocaine-Prilocaine Cream 30GM medical products. The contract has an ultimate completion date of September 15, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of medical supplies, specifically Lidocaine-HC 3-0.5% cream kits. The award, valued at $1,686.58, is a delivery order with a firm fixed price contract type, and the ultimate completion date is December 27, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,574.88 firm fixed price delivery order is for the supply of 30 gram tubes of Lidocaine-Prilocaine Cream, a topical anesthetic medication. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., is for the delivery of Lidocaine-Prilocaine Cream 30GM to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,421.45 and an ultimate completion date of September 27, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,126.27 fixed-price delivery order is for the supply of Lidocaine-Prilocaine Cream, a topical anesthetic medication. The contract has a completion date of May 25, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $7,218.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine HCL 4% Solution, a pharmaceutical product, to support military healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN3C2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,409.90 firm fixed-price delivery order is for the supply of Lidocaine-Prilocaine Cream, a pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This specific delivery order was not designated with a set-aside requirement, indicating full and open competition. The contract supports the medical and pharmaceutical needs of the U.S. military and veteran healthcare programs administered by the DLA.

Generated 2/27/25, 9:58 AM